ThomasMFarrellMD

PubMed

• 18 citations
  5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk).
  Michael P. Winters, Darius Robinson, Hnin Hnin Khine, Steven S. Pullen, Joseph R. Woska, Ernest L. Raymond, Rosemarie Sellati, Charles L. Cywin, Roger J. Snow, Mohamme...> ;Bioorganic & Medicinal Chemistry Letters. 2008 Oct 15
• 19 citations
  Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead.
  Kevin J. Moriarty, Michael P. Winters, Lei Qiao, Declan Ryan, Renee DesJarlis, Darius Robinson, Brian Nicholas Cook, Mohammed A. Kashem, Paul Kaplita, Lisa H. Liu, Tho...> ;Bioorganic & Medicinal Chemistry Letters. 2008 Oct 15
• 54 citations
  Discovery of potent and selective PKC-θ inhibitors
  Charles L. Cywin, Georg Dahmann, Anthony S. Prokopowicz, Erick R. R. Young, Ronald L. Magolda, Mario G. Cardozo, Derek Cogan, Darren Disalvo, John D. Ginn, Mohammed A....> ;Bioorganic & Medicinal Chemistry Letters. 2007 Jan 1
• Assessment of physician perceptions on the fatality of cancer.
  Q. Scott Ringenberg, Thomas M. Farrell, John C. Reid, John E. Hewett, John W. Yarbro, Jayendra H. Shah> ;Journal of Cancer Education. 1991 Jan 1
• High throughput quantitative assessment of CYP inactivation using 2 concentration points.
  Albaugh, D., Farrell, T., Langan, M., Lai, W. G.> ;Drug Metab Lett. 2009 Apr 01
• Join now to see all